Brain responses to methylphenidate in adult ADHD and mood-related attention difficulties
About this title
Read the official source — NCT05832489Understand this study
Who could participate?
Listed age limits: 18 years to 60 years.
What will I do during this study?
Participants in each group complete two MRI (magnetic resonance imaging) and EEG (recording of the brain’s electrical activity) imaging sessions in a crossover design, receiving methylphenidate before one session and placebo (an inactive comparison treatment) before the other. The study includes adults with ADHD (attention deficit hyperactivity disorder), adults with attention difficulties associated with mood conditions, and healthy controls.
- Listed locations
- StrasbourgSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 80
- Sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT05832489
- Official title
Show the full official title
EEG-MRI Study of the Effect of Methylphenidate on Neural Mechanisms in Adult Patients With ADHD With or Without Mood Disorders: a Randomized Controlled Trial Versus Placebo
Recruitment & locations
Strasbourg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Strasbourg, France, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Placebo and Methylphenidate immediate release 25mg.
Who can participate?
Listed age limits: 18 years to 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
